Developing Costimulatory Molecules for Immunotherapy of Diseases

Manzoor Ahmad Mir

Anno: 2015
Rilegatura: Paperback / softback
Pagine: 322 p.
Testo in English
Dimensioni: 229 x 152 mm
Peso: 540 gr.
  • EAN: 9780128025857
pagabile con 18App pagabile con Carta del Docente

Articolo acquistabile con 18App e Carta del Docente

€ 113,53

€ 123,40

Risparmi € 9,87 (8%)

Venduto e spedito da IBS

114 punti Premium

Disponibile in 4/5 settimane

Developing Costimulatory Molecules for Immunotherapy of Diseases highlights the novel concept of reverse costimulation and how it can be effectively exploited to develop immunotherapy using either humanized antibodies against CD80, CD86, and other costimulatory molecules or CD28 fusinogenic proteins in the treatment of diseases, including allergies, asthma, rheumatoid arthritis, multiple sclerosis, lupus nephritis, severe psoriasis, vulgaris tuberculosis, thopoid, transplantation therapeutic, cancer, and inflammation. The text aims to provide the latest information on the complex roles and interactions within the CD28 and B7 costimulatory families, with the hope that targeting these families will yield new therapies for the treatment of inflammation, autoimmunity, transplantation, cancer, and other infectious diseases.